Siga Technologies (SIGA) Non-Current Assets (2010 - 2025)
Siga Technologies' (SIGA) quarterly Non-Current Assets came in at $6.6 million in Q4 2025, down 50.27% YoY from $13.3 million in Q4 2024, and up 71.36% on a QoQ basis from $3.9 million in Q3 2025.
Siga Technologies (SIGA) Non-Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Non-Current Assets data on file, last reported at $6.6 million in Q4 2025.
- Quarterly Non-Current Assets fell 50.27% year-over-year to $6.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.0 million (down 49.42% YoY) and the FY2025 annual result came in at $6.6 million, down 50.27% from the prior year.
- Non-Current Assets rose to $6.6 million in Q4 2025, from $3.9 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $16.2 million in Q2 2024 to a low of $3.9 million in Q3 2025.
- A 5-year average of $9.8 million and a median of $8.3 million in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets soared 93.94% — and 2025, when it tumbled 73.7%.
- Tracing SIGA's Non-Current Assets over 5 years: stood at $6.0 million in 2021, then jumped by 54.84% to $9.2 million in 2022, then surged by 66.08% to $15.4 million in 2023, then dropped by 13.47% to $13.3 million in 2024, then sank by 50.27% to $6.6 million in 2025.
- The last three Non-Current Assets figures came in at $6.6 million (Q4 2025), $3.9 million (Q3 2025), and $6.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.96 Bn |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - | 6.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.61 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 13.45 Mn |
| Dec 31, 2024 | 13.29 Mn |
| Sep 30, 2024 | 14.67 Mn |
| Jun 30, 2024 | 16.18 Mn |
| Mar 31, 2024 | 15.25 Mn |
| Dec 31, 2023 | 15.36 Mn |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.21 Mn |
| Mar 31, 2023 | 11.39 Mn |
| Dec 31, 2022 | 9.25 Mn |
| Sep 30, 2022 | 7.32 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 7.44 Mn |
| Dec 31, 2021 | 5.97 Mn |
| Sep 30, 2021 | 6.63 Mn |
| Jun 30, 2021 | 6.62 Mn |
| Mar 31, 2021 | 5.88 Mn |